Real tDCS

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Novartis
NovartisBASEL, Switzerland
1 program
real anodal transcranial direct current stimulationN/A1 trial
Active Trials
NCT03959462Completed254Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novartisreal anodal transcranial direct current stimulation

Clinical Trials (1)

Total enrollment: 254 patients across 1 trials

NCT03959462Novartisreal anodal transcranial direct current stimulation

Supporting Decisions With Transcranial Direct Current Stimulation in Healthy Young and Elderly Individuals

Start: Mar 2018Est. completion: Dec 2022254 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space